Moxifloxacin oral preparation and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of moxifloxacin and preparations, applied in the field of moxifloxacin oral preparations and its preparation, can solve the problems of high cost and expensive lactose, and achieve the effects of easy purchase, good stability and cheap excipients
Active Publication Date: 2010-11-24
JIANGSU YABANG QIANGSHENG PHARMA
View PDF2 Cites 16 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0005] However, the price of lactose is more expensive, and the cost of preparing moxif
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0040] Embodiment 1: (tablet is calculated on the basis of uncoated)
[0041] Moxifloxacin hydrochloride 437.9mg
[0042] Soluble starch 20.0mg
[0043] Pregelatinized starch 10.0mg
[0044] Microcrystalline Cellulose 160.0mg
[0045] Croscarmellose Sodium 25.0mg
[0046] Magnesium stearate 13.8mg
Embodiment 2
[0047] Embodiment 2: (tablet is calculated on the basis of uncoated)
[0048] Moxifloxacin hydrochloride 437.9mg
[0049] Soluble starch 35.0mg
[0050] Pregelatinized starch 15.0mg
[0051] Microcrystalline Cellulose 145.0mg
[0052] Croscarmellose Sodium 25.0mg
[0053] Magnesium Stearate 13.2mg
Embodiment 3
[0054] Embodiment 3: (tablet is calculated on the basis of uncoated)
[0055] Moxifloxacin hydrochloride 437.9mg
[0056] Soluble starch 45.0mg
[0057] Pregelatinized starch 45.0mg
[0058] Microcrystalline Cellulose 95.0mg
[0059] Croscarmellose Sodium 25.0mg
[0060] Magnesium Stearate 13.2mg
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to an oral pharmaceutical preparation containing moxifloxacin, salts and/or hydrates of the moxifloxacin, soluble starch and pregelatinized starch. The preparation is characterized by containing 2.9%-14.5% of soluble starch and 1.4%-6.5% of pregelatinized starch, wherein all percents are calculated on the basis of the weight of the pharmaceutical preparation. The invention also relates to a preparation method of the preparation and an application of the preparation for treating or preventing bacterial infection of people or animals.
Description
technical field [0001] The invention relates to an oral pharmaceutical preparation containing moxifloxacin, its salt and / or hydrate, soluble starch and pregelatinized starch and a preparation method thereof. Background technique [0002] Moxifloxacin (moxifloxacin) is a new generation of fluoroquinolone antibacterial drugs, which has the advantages of broad antibacterial spectrum, strong antibacterial activity, and small toxic and side effects. It can be used to prevent or treat bacterial infections in humans or animals, such as upper and lower respiratory tract infections and skin infections. and soft tissue infections. The chemical name of moxifloxacin is: 1-cyclopropyl-7-[(S,S)-2,8-diazo-bicyclo[4.3.0]non-8-yl]-6-fluoro-1, 4-Dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid, the chemical structure is as follows: [0003] [0004] Bayer Company has described in Chinese patent (patent No. ZL89104574.0) containing moxifloxacin or its salt, microcrystalline cellulose, c...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more